AWM
GILD icon

Aviso Wealth Management’s Gilead Sciences GILD Stock Holding History

Aviso Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$656K Buy
5,193
+789
+18% +$104K 0.22% 78
2026
Q1 		$614K Sell
4,404
-303
-6% -$42.4K 0.28% 77
2025
Q4 		$578K Buy
4,707
+778
+20% +$94.5K 0.24% 84
2025
Q3 		$436K Sell
3,929
-6
-0.2% -$682 0.19% 97
2025
Q2 		$436K Buy
3,935
+531
+16% +$56.5K 0.2% 96
2025
Q1 		$381K Sell
3,404
-17
-0.5% -$1.75K 0.2% 101
2024
Q4 		$316K Sell
3,421
-259
-7% -$23.3K 0.16% 110
2024
Q3 		$309K Sell
3,680
-82
-2% -$6.26K 0.17% 114
2024
Q2 		$258K Sell
3,762
-148
-4% -$9.88K 0.15% 124
2024
Q1 		$286K Buy
3,910
+140
+4% +$10.8K 0.18% 119
2023
Q4 		$305K Buy
+3,770
New +$293K 0.22% 105

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aviso Wealth Management's GILD Position: Q2 2026 in Review

Aviso Wealth Management increased its Gilead Sciences (GILD) stake by 18% in Q2 2026, buying an estimated $104K and bringing the position to 5,193 shares worth $656K. The position accounts for 0.22% of the portfolio, ranked #78.

Aviso Wealth Management first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Aviso Wealth Management held 5,193 shares of Gilead Sciences worth $656K as of Q2 2026.
  • Aviso Wealth Management bought 789 Gilead Sciences shares in Q2 2026, an estimated $104K.
  • Gilead Sciences made up 0.22% of Aviso Wealth Management's portfolio in Q2 2026, its #78 holding.
  • Aviso Wealth Management first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Aviso Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.